Market Revenue Glucose Biosensor Industry Value Chain Analysis

over the forecast period. Asia Pacific is expected to grow rapidly over the forecast period owing to increasing aging population coupled with increasing consumer awareness about these devices. Some of the key players in the market are as follows Roche, Abbott, Siemens Healthcare Diagnostics, Nova Biomedical Corp, Animas Corporation, M-Biotech, LifeScan, AgaMatrix, Medtronic Diabetes and others. In present years, carbon nanotubes have got extensive attention as capable carbon-based nanoelectronic equipment owing to their exceptional chemical, physical and electrical properties, specifically a soaring surface- to-volume proportion, their superior electron transfer properties, and their soaring thermal conductivity, carbon nanotubes are being utilized efficiently as electrochemical sensors. The incorporation of carbon nanotubes as a functional group offers a solid and good support for the control of enzymes and their integration with glucose biosensors offers a quick detection rate and high accuracy. A number of R&D initiatives are being taken by active players in the market to capture maximum revenue and thus offer that devices which are highly précised. Market Segment: Glucose Biosensors End-use Outlook (Revenue, USD Million, 2012 - 2022) • Hospitals • Homecare Diagnostics • Others Biosensors Regional Outlook (Revenue, USD Million, 2012 - 2022) • North America • U.S. • Canada • Europe • UK • Germany • Asia Pacific • China • India • Latin America • Brazil • Mexico • MEA See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices

Market Revenue Glucose Biosensor Industry Value Chain Analysis | Page 3